-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-promotion-behavioral-counseling-1996
January 01, 1996 - on the patient's nutritional status, underlying medical disorders, functional status, dentition, and therapeutic … Surveillance for diabetes mellitus: United States, 1980-1989. … Diabetes . 1986;35:155–164. [ PubMed ] 19. MacMahon S, Cutler J, Brittain E, et al. … Dietary therapy slows the return of hypertension after stopping prolonged medication. … Treatment of spinal osteoporosis in postmenopausal women.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
January 01, 2017 - Trials of CPAP and other treatments have not established whether treatment
reduces mortality or improves … Trials of CPAP and other treatments have
not established whether treatment reduces mortality or improves … Improving activity
in adults with diabetes and coexisting obstructive
sleep apnea. … Randomised prospective parallel trial of therapeutic
versus subtherapeutic nasal continuous positive … Surgical vs conventional therapy for weight loss
treatment of obstructive sleep apnea:
a randomized controlled
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-2010
January 15, 2010 - Limited evidence suggests that these improvements can be sustained over the year after treatment. … have a sizeable health impact. 5 , 6 Obese children and adolescents have an increased risk of type 2 diabetes … Multicomponent behavioral interventions and interventions that combined behavioral and pharmacologic treatments … Surgical treatments, which are reserved for morbidly obese patients who are identified without the need … Combined Pharmacologic and Behavioral Interventions
Seven trials combined pharmacologic treatments
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors
October 15, 2009 - Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise … Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. … Diabetes Care . 2002;25:1845-50. … Diabetes Care . 1997;20:935-42. … The San Luis Valley Diabetes Study. Circulation . 1995;91:1472-9.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
October 15, 2009 - Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise … Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. … Diabetes Care . 2002;25:1845-50. … Diabetes Care . 1997;20:935-42. … The San Luis Valley Diabetes Study. Circulation . 1995;91:1472-9.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
March 02, 2020 - Sustained virologic response after antiviral therapy was consistently associated with decreased risk … Direct-acting antiviral regimens are associated with fewer harms than older interferon-containing therapies … for headache and were also lower when compared with rates reported for older interferon-containing therapies … function, and extrahepatic effects of HCV infection (eg, renal function, cardiovascular effects, or diabetes … Currently recommended DAA regimens are associated with fewer harms than older interferon-containing therapies
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkAWAdFHNkePeKEqUcH8AL
May 25, 2021 - Meta-analysis of Trials: Mean Gestational Weight Gain
–8 –6 –2 420 6–4
Mean difference
(95% CI)
Favors
treatment … Favors
control
Treatment
Mean gestational weight gain
No. … Diabetes Care. 2016;39(1):24-30. … The
Treatment of Obese Pregnant women (TOP) study:
a randomized controlled trial of the effect of
physical … Randomized controlled trial of home-based lifestyle
therapy on postpartum weight in underserved
women
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/cvd-nontraditional-risk-pad-joint-bulletin.pdf
July 10, 2018 - for someone’s risk of CVD by looking at traditional risk factors such as age, race/ethnicity,
sex, diabetes … information on risk, we could not determine whether this was enough to help clinicians make better
treatment
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/8uE22djVfm8hF8wNg7wWYn
May 01, 2021 - with iron therapy … with iron
therapy.1 To establish the presence of iron deficiency or iron defi-
ciency anemia, levels … variability,
limiting interpretation of this evidence.1,17 In 4 trials reporting ma-
ternal gestational diabetes … and uncertain.1,17 Two trials24,26 (n = 2214) found no dif-
ferences in rates of maternal gestational diabetes … Iron
supplement in pregnancy and development of
gestational diabetes—a randomised
placebo-controlled
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
June 26, 2018 - Pharmacologic treatments for osteoporosis inhibit osteoclastic bone resorption (antiresorptive agents … Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. … TBS (trabecular bone score) and diabetes-related fracture risk. … disease, i living in a nursing home, i COPD, i cancer, i lupus, i anticonvulsant use, i type 1 diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Pharmacologic treatments for osteoporosis inhibit osteoclastic bone resorption (antiresorptive agents … Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. … TBS (trabecular bone score) and diabetes-related fracture risk. … disease, i living in a nursing home, i COPD, i cancer, i lupus, i anticonvulsant use, i type 1 diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tf-new-member-bulletin-2021.pdf
January 01, 2021 - Davis has expertise in family medicine, and her research focuses on tobacco cessation, gestational
diabetes … Pittsburgh School of Medicine and the director of the University of Pittsburgh Medical Center
Tobacco Treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - isoniazid and 1.1% for rifampin. 131 Meta-analysis found no statistically significant difference between treatments … It is unclear whether changes in the prevalence of tuberculosis (which has decreased), treatments for … noninferiority, improved adherence, and lower risk of hepatotoxicity for current, CDC-preferred LTBI treatments … The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RRALFxUMfP7TXazQY32ZbG
June 12, 2018 - each included study, 1 investigator extracted pertinent informa-
tion about the populations, tests or treatments … benefits and harms
of preventive medications to reduce cardiovascular risk (ie, aspirin and
lipid-lowering therapy … Those with positive findings were
referred to cardiologists, and all subsequent investigations and treatments … f Antihypertensive treatment received by 74.3% of study patients; mean
systolic blood pressure, 140 mm … Effect of statin
treatment vs usual care on primary cardiovascular
prevention among older adults: the
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan6/high-blood-pressure-in-adults-screening
September 15, 2013 - for confirmation (or no confirmation) of the diagnosis of hypertension at a subsequent encounter, and treatment … *Elevated blood pressure is defined as the threshold for pharmacologic treatment. … underlying causes of high blood pressure, and highly selected groups of patients (e.g., patients with diabetes … Analytic Framework, elevated blood pressure is now generally defined as the threshold for pharmacologic treatment … Additional comments addressed issues already covered by the Key Questions, treatment questions that this
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan6/high-blood-pressure-in-adults-screening-october-2015
September 15, 2013 - for confirmation (or no confirmation) of the diagnosis of hypertension at a subsequent encounter, and treatment … *Elevated blood pressure is defined as the threshold for pharmacologic treatment. … underlying causes of high blood pressure, and highly selected groups of patients (e.g., patients with diabetes … Analytic Framework, elevated blood pressure is now generally defined as the threshold for pharmacologic treatment … Additional comments addressed issues already covered by the Key Questions, treatment questions that this
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan6/high-blood-pressure-in-adults-screening-monitoring-october-2015
September 15, 2013 - for confirmation (or no confirmation) of the diagnosis of hypertension at a subsequent encounter, and treatment … *Elevated blood pressure is defined as the threshold for pharmacologic treatment. … underlying causes of high blood pressure, and highly selected groups of patients (e.g., patients with diabetes … Analytic Framework, elevated blood pressure is now generally defined as the threshold for pharmacologic treatment … Additional comments addressed issues already covered by the Key Questions, treatment questions that this
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening-january-2017
January 24, 2017 - health outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular events, diabetes … In addition, studies that evaluate the effect of OSA treatments or interventions on health outcomes ( … USPSTF reviewed evidence from 50 fair- to good-quality trials that evaluated the effect of various treatments … Thus, it is unclear whether treatments that improve AHI would also improve mortality. … A subset of studies that evaluated the effectiveness of various OSA treatments also reported on harms
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - Good evidence indicates that both the testing strategy and the treatment with carotid endarterectomy … Because the magnitude of potential surgical harms is such an important consideration in the treatment … study, and would not have included treatments that are now considered to be optimal medical management … It is difficult to determine what effect current standard medical therapy would have on overall benefit … individuals age 55 years or older with cardiovascular risk factors, such as a history of hypertension, diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/thyroid-cancer-screening
May 09, 2017 - treatment). … surgery, radioactive iodine therapy), and type of outcome. … , with or without lymph node dissection (unilateral, bilateral, or not specified; and prophylactic, therapeutic … National Cancer Institute; Centers for Disease Control and Prevention; and the National Institute of Diabetes … and Digestive and Kidney Diseases, Diabetes, Endocrinology, and Obesity Branch).